Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Paladin Labs has filed a new drug submission or NDA for Seasonique with the Therapeutic Products Directorate of Health Canada for the prevention of pregnancy.
Subscribe to our email newsletter
Paladin signed a license and distribution agreement with Duramed Pharmaceuticals, a wholly owned subsidiary of Barr Pharmaceuticals, which granted Paladin the exclusive Canadian license to market Seasonique.
Jonathan Ross Goodman, president and CEO of Paladin, said: “Seasonique is an excellent strategic fit to our strong women’s health franchise. Seasonique complements Seasonale in offering Canadian women an additional, innovative option in birth control. Like Seasonale, Seasonique is a unique extended-cycle birth control pill.”